ResMed (RMD) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $219.95 -0.5%
Revenue Growth %: +6.9%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
SUNB, CULP, KFY, More
Revenue Growth %: +6.9%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $1.49, $0.04 better than the analyst estimate of $1.45. Revenue for the quarter came in at $914.7 million versus the consensus estimate of $910.54 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
- Cognyte Software (CGNT) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
